Gosta Labs Secures $8.2 Million to Revolutionize Cancer Care with AI
November 28, 2025, 3:35 pm
Finnish startup Gosta Labs raises $8.2M to scale its AI OS for oncology. The system eases clinician workload and personalizes patient care. AI streamlines documentation and integrates guidelines. The goal: better, faster oncology care.
Helsinki-based Gosta Labs has secured $8.2 million in seed funding. The funds will scale its AI-powered operating system for oncology. The technology aims to ease the growing burden on cancer care teams.
The funding round was led by Voima Ventures. COR Group, the Aho family, Reaktor, and angel investors also participated. This follows a $1.8 million pre-seed round in 2024. Total funding now approaches $10 million.
Gosta Labs' AI system targets the increasing complexity of cancer care. By 2050, experts project 35 million new cancer cases annually. Clinicians currently spend hours on administrative tasks. Data is fragmented, and treatment decisions are complex.
Gosta Labs' AI addresses these problems. The system transforms patient visits into structured data. It summarizes patient journeys and automates documentation. It captures data relevant to care and assesses treatment pathways. The system links decisions to international guidelines.
The AI operating system aims to improve care quality. It also seeks to reduce oncologist workloads.
Early results presented at the ESMO 2025 Congress are promising. The system generates high-quality consultation notes. Notes are structured and meet institutional standards. The AI classifies performance status and toxicity grades automatically.
Oncologists using the system completed follow-up documentation quickly. The median time was under two minutes. This significantly reduces documentation time. Clinicians can spend more time with patients.
Gosta Labs was founded in 2023 by Lauri Sippola and Henri Viertolahti. They previously founded Kaiku Health, which Elekta acquired in 2020. The Gosta Labs team combines AI expertise with oncology and medtech experience. Dr. Lionel Hadjadjeba is the Chief Medical Officer. Reetta Arokoski is the Chief Operating Officer.
The new funding will expand the AI assistant's reach. Gosta Labs will strengthen its product and AI foundation. The goal is safer, more personalized patient care. Administrative burdens will be reduced.
The company's technology has impressed early users. Dr. Razvan Popescu, Medical Director at Tumor Center Aargau, noted a significant reduction in documentation time. The AI system frees oncologists to focus on patients. Documentation time has been cut by over two-thirds per patient visit.
The company partners with healthcare providers in Finland, Switzerland, the Baltics, and Australia. Gosta Labs' technology aims to reshape clinical workflows.
Gosta Labs stands out in the European HealthTech landscape. Several other oncology and AI startups have also secured funding. CGC Genomics raised $1.8 million. Perci Health secured $4.3 million. Sycai Medical obtained $3.2 million. BIMINI Biotech raised $3.2 million.
Gosta Labs' seed round is one of the larger in the oncology-AI sector this year. The company's location in Finland is also notable. Finland does not appear among other 2025 oncology-AI fundings.
Gosta Labs is poised to make a significant impact. Their AI operating system addresses critical challenges in cancer care. The funding will accelerate their growth. The future of oncology may be shaped by AI.
"
Gosta Labs Secures $8.2 Million to Revolutionize Cancer Care with AI
Helsinki-based Gosta Labs has secured $8.2 million in seed funding. The funds will scale its AI-powered operating system for oncology. The technology aims to ease the growing burden on cancer care teams.
The funding round was led by Voima Ventures. COR Group, the Aho family, Reaktor, and angel investors also participated. This follows a $1.8 million pre-seed round in 2024. Total funding now approaches $10 million.
Gosta Labs' AI system targets the increasing complexity of cancer care. By 2050, experts project 35 million new cancer cases annually. Clinicians currently spend hours on administrative tasks. Data is fragmented, and treatment decisions are complex.
Gosta Labs' AI addresses these problems. The system transforms patient visits into structured data. It summarizes patient journeys and automates documentation. It captures data relevant to care and assesses treatment pathways. The system links decisions to international guidelines.
The AI operating system aims to improve care quality. It also seeks to reduce oncologist workloads.
Early results presented at the ESMO 2025 Congress are promising. The system generates high-quality consultation notes. Notes are structured and meet institutional standards. The AI classifies performance status and toxicity grades automatically.
Oncologists using the system completed follow-up documentation quickly. The median time was under two minutes. This significantly reduces documentation time. Clinicians can spend more time with patients.
Gosta Labs was founded in 2023 by Lauri Sippola and Henri Viertolahti. They previously founded Kaiku Health, which Elekta acquired in 2020. The Gosta Labs team combines AI expertise with oncology and medtech experience. Dr. Lionel Hadjadjeba is the Chief Medical Officer. Reetta Arokoski is the Chief Operating Officer.
The new funding will expand the AI assistant's reach. Gosta Labs will strengthen its product and AI foundation. The goal is safer, more personalized patient care. Administrative burdens will be reduced.
The company's technology has impressed early users. Dr. Razvan Popescu, Medical Director at Tumor Center Aargau, noted a significant reduction in documentation time. The AI system frees oncologists to focus on patients. Documentation time has been cut by over two-thirds per patient visit.
The company partners with healthcare providers in Finland, Switzerland, the Baltics, and Australia. Gosta Labs' technology aims to reshape clinical workflows.
Gosta Labs stands out in the European HealthTech landscape. Several other oncology and AI startups have also secured funding. CGC Genomics raised $1.8 million. Perci Health secured $4.3 million. Sycai Medical obtained $3.2 million. BIMINI Biotech raised $3.2 million.
Gosta Labs' seed round is one of the larger in the oncology-AI sector this year. The company's location in Finland is also notable. Finland does not appear among other 2025 oncology-AI fundings.
Gosta Labs is poised to make a significant impact. Their AI operating system addresses critical challenges in cancer care. The funding will accelerate their growth. The future of oncology may be shaped by AI.
"